EMPLOYMENT AGREEMENT (Revised)Employment Agreement • February 28th, 2020 • Dicerna Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
EMPLOYMENT AGREEMENT (“Agreement”) made this February 21, 2020 (the “Effective Date”) between Dicerna Pharmaceuticals, Inc., a Delaware corporation (“Company”), on the one hand and Ralf Rosskamp (the “Executive”) on the other hand.
SHARE ISSUANCE AGREEMENTShare Issuance Agreement • February 28th, 2020 • Dicerna Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS SHARE ISSUANCE AGREEMENT (this “Agreement”), is made as of November 15, 2019, by and between Novo Nordisk A/S, a public limited liability company (the “Share Acquiror”), and Dicerna Pharmaceuticals, Inc., a Delaware corporation (the “Company”).
COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • February 28th, 2020 • Dicerna Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS COLLABORATION AND LICENSE AGREEMENT (the “Agreement”), entered into as of November 15, 2019 (the “Signing Date”) is by and between NOVO NORDISK A/S, a corporation organized and existing under the laws of Denmark, having an address at Novo Allé, 2880 Bagsvaerd, Denmark, CVR No. 24 25 67 90 (“Novo”), on the one hand, and DICERNA PHARMACEUTICALS, INC., a corporation organized and existing under the laws of Delaware, with its principal place of business at 33 Hayden Avenue, Lexington, Massachusetts 02421, U.S.A. (“Dicerna”), on the other hand. Dicerna and Novo are each referred to individually as a “Party” and together as the “Parties”.
February 21, 2020 Douglas M. Fambrough, III, Ph.D. Re: Amendment to Employment Agreement Dear Mr. Fambrough:Employment Agreement • February 28th, 2020 • Dicerna Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
This letter agreement (the “Amendment”) by and between yourself and Dicerna Pharmaceuticals, Inc. (the “Company”) is intended to amend that certain Amended and Restated Employment Agreement between you and the Company, dated July 8, 2016 (the “Agreement”). This Amendment is effective as of February 25, 2020. Capitalized terms used, but not defined herein shall have the meanings given to such terms in the Agreement.
FIRST AMENDMENT TO LEASE AGREEMENTLease Agreement • February 28th, 2020 • Dicerna Pharmaceuticals Inc • Pharmaceutical preparations • Colorado
THIS FIRST AMENDMENT TO LEASE AGREEMENT (this “First Amendment”) is entered into effective as of February 4, 2020 (the “First Amendment Date”), by and between WESTERN OFFICE PORTFOLIO PROPERTY OWNER LLC, a Delaware limited liability company (“Landlord”), and DICERNA PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”).
EMPLOYMENT AGREEMENTEmployment Agreement • February 28th, 2020 • Dicerna Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
EMPLOYMENT AGREEMENT ("Agreement") made this 3rd of June 2019 (the "Effective Date") between Dicerna Pharmaceuticals, Inc., a Delaware corporation ("Company"), on the one hand and Robert Ciappenelli (the "Executive") on the other hand.
Collaboration and License AgreementCollaboration and License Agreement • February 28th, 2020 • Dicerna Pharmaceuticals Inc • Pharmaceutical preparations • New York
LEXINGTON, MASSACHUSETTS 02421 LEASE SUMMARY SHEETIndenture of Lease • February 28th, 2020 • Dicerna Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
Execution Date: January 14, 2020 Tenant: DICERNA PHARMACEUTICALS, INC., a Delaware corporation Tenant’s Mailing Address: 33 Hayden AvenueLexington, MA 02421Attn: David W. Miller, PhD, SVP Landlord: HCP/KING 75 HAYDEN LLC,a Delaware limited liability company Building: 75 Hayden Avenue, Lexington, Massachusetts 02421. The Building is currently under construction and shall consist of four (4) stories and contain approximately 214,440 rentable square feet. The land (the “Land”) on which the Building is located is described as “Building 75” on Exhibit 2A attached hereto and made a part hereof. Campus: All of the land described on Exhibit 2B (including the Land described above, which Land is a portion of the land described on Exhibit 2B) together with the Building described above, the buildings now known as and numbered 45 Hayden Avenue, 55 Hayden Avenue and 65 Hayden Avenue (“Building 65”), and any other building and/or improvements constructed on the Land. The Campus includes an existing n
John B. Green Lowell, MA 01852 Re: Transition AgreementTransition Agreement • February 28th, 2020 • Dicerna Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
This Agreement amends the Employment Agreement and the Amended and Restated Indemnification Agreement dated April 11, 2017 between you and the Company (the “Indemnification Agreement”). It also amends certain Equity Documents, as defined below.
